Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Omaha hosts numerous active clinical trials targeting diseases such as cancer, asthma, and autoimmune disorders like lupus. The city’s leading research institutions are recruiting participants, both as a healthy volunteer and those looking for studies related to specific health conditions, offering opportunities to take part in groundbreaking research and access innovative treatments.
Filter
2
Filter results
Results: 602
First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
for
Healthy Participants
Location: Lincoln NE
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT07412288
Phase1, Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for
Obesity With Diabetes, Overweight With Diabetes
Location: Lincoln NE, Newton KS, Skokie IL, Chickasha OK,
Sponsor: Kailera
Sex: All
Age: 18+
Code: NCT07284901
Phase3, Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
for
Healthy Participants
Location: Lincoln NE
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18 - 55
Code: NCT07377539
Phase1, Recruiting
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
for
Osteoarthritis (OA) of the Knee
Location: Lincoln NE, Daytona Beach FL, Huntington Beach CA
Sponsor: Pacira Pharmaceuticals, Inc
Sex: All
Age: 45 - 70+
Code: NCT06884865
Phase2, Recruiting
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
for
Psoriatic Arthritis
Location: Lincoln NE, Kansas City MO, Houston TX, Duncansville PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07486960
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Lincoln NE, Kansas City MO, St Louis MO, Willowbrook IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase2, Recruiting
Home With TablO outcoMEs (HOME) Registry
for
End Stage Renal Disease
Location: Lincoln NE, Plano TX, Helena MT, New York NY,
Sponsor: Outset Medical
Sex: All
Age: 15+
Code: NCT04526301
Recruiting
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Location: Lincoln NE, Carroll IA, Waukee IA, Des Moines IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Council Bluffs IA, Omaha NE, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Omaha NE, Indianapolis IN, Caledonia MI, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
Featured
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for
Atopic Dermatitis
Location: Omaha NE, Lincoln NE, Saint Joseph MO, Fayetteville AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT06389136
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Omaha NE, Minneapolis MN, Chicago IL, Indianapolis IN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis